Stock listing
NASDAQ:DYN Dyne Therapeutics, Inc. Stock
Home listing (NASDAQ) of Dyne Therapeutics, Inc.
Follow Dyne Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:DYN
$16.69 USD -0.35 (-2.1%)
Close on Oct 30, 2026
- Day range
- $16.34 – $17.19 USDOct 30, 2026
- Volume
- 1.45M sharesOct 30, 2026
- Market cap
- $3.12B USDAt the close on Oct 30, 2026 · price × 186.7M shares outstanding
- 52-week range
- $14.00 – $27.31 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $53.15M USDMedian day 2.18M shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:DYN · Home | $16.69 USD | -0.35 (-2.1%) | 1,449,801 | $17.04 | $17.19 | $16.34 | $17.04 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:DYN · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $16.69 | -0.35 | -2.1% | $17.04 | $17.19 | $16.34 | 1,449,801 | |
| $17.04 | +0.06 | +0.4% | $17.20 | $17.59 | $16.75 | 1,427,300 | |
| $16.98 | +0.04 | +0.2% | $16.30 | $17.12 | $16.11 | 2,177,500 | |
| $16.94 | +1.22 | +7.8% | $15.80 | $16.97 | $15.73 | 3,002,000 | |
| $15.72 | +0.10 | +0.6% | $15.64 | $16.02 | $15.53 | 1,741,900 | |
| $15.62 | -0.15 | -1.0% | $15.92 | $15.92 | $15.32 | 2,134,300 | |
| $15.77 | -0.30 | -1.9% | $15.99 | $16.34 | $15.67 | 2,052,500 | |
| $16.07 | -0.20 | -1.2% | $16.33 | $16.73 | $15.91 | 1,789,800 | |
| $16.27 | +1.04 | +6.8% | $15.27 | $16.56 | $15.14 | 3,405,300 | |
| $15.23 | +0.98 | +6.9% | $14.45 | $15.38 | $14.45 | 3,346,200 | |
| $14.25 | -1.04 | -6.8% | $15.21 | $15.49 | $14.13 | 2,860,500 | |
| $15.29 | +0.25 | +1.7% | $15.15 | $15.47 | $15.04 | 2,074,600 | |
| $15.04 | -0.26 | -1.7% | $15.11 | $15.42 | $14.71 | 2,195,900 | |
| $15.30 | -0.66 | -4.1% | $15.97 | $15.99 | $15.28 | 3,341,600 | |
| $15.96 | -0.68 | -4.1% | $16.54 | $16.76 | $15.73 | 2,915,100 | |
| $16.64 | +0.27 | +1.6% | $16.41 | $17.31 | $16.36 | 3,565,900 | |
| $16.37 | +0.40 | +2.5% | $15.84 | $16.47 | $15.35 | 6,279,500 | |
| $15.97 | +0.57 | +3.7% | $15.40 | $16.12 | $15.25 | 3,489,900 | |
| $15.40 | -0.04 | -0.3% | $15.50 | $15.59 | $14.93 | 4,098,700 | |
| $15.44 | +0.24 | +1.6% | $15.31 | $15.54 | $15.08 | 4,377,300 | |
| $15.20 | -0.62 | -3.9% | $16.03 | $16.03 | $15.09 | 2,534,100 | |
| $15.82 | -0.29 | -1.8% | $16.01 | $16.28 | $15.52 | 3,699,400 | |
| $16.11 | -0.10 | -0.6% | $16.05 | $16.80 | $15.92 | 4,456,500 | |
| $16.21 | -0.13 | -0.8% | $16.40 | $16.55 | $15.97 | 2,287,000 | |
| $16.34 | +0.31 | +1.9% | $15.86 | $16.43 | $15.63 | 2,305,800 | |
| $16.03 | -0.48 | -2.9% | $16.62 | $16.76 | $16.02 | 1,612,100 | |
| $16.51 | +0.28 | +1.7% | $16.09 | $16.65 | $15.88 | 3,197,700 | |
| $16.23 | -0.91 | -5.3% | $17.08 | $17.08 | $16.18 | 2,636,200 | |
| $17.14 | +0.02 | +0.1% | $17.39 | $17.59 | $17.06 | 2,627,000 | |
| $17.12 | +0.01 | +0.1% | $17.31 | $17.59 | $16.75 | 3,219,800 | |
| $17.11 | -0.95 | -5.3% | $18.07 | $18.15 | $16.96 | 4,849,100 | |
| $18.06 | +0.755 | +4.4% | $17.90 | $18.11 | $17.62 | 2,846,800 | |
| $17.31 | -0.595 | -3.3% | $18.37 | $18.37 | $17.09 | 2,156,000 | |
| $17.90 | -0.62 | -3.3% | $18.52 | $18.62 | $17.87 | 3,029,200 | |
| $18.52 | +0.31 | +1.7% | $18.40 | $19.15 | $18.27 | 3,196,900 | |
| $18.21 | -0.21 | -1.1% | $18.59 | $18.74 | $17.94 | 3,774,300 | |
| $18.42 | -0.77 | -4.0% | $19.03 | $19.03 | $17.93 | 4,709,500 | |
| $19.19 | -1.12 | -5.5% | $19.38 | $20.16 | $18.97 | 5,143,000 | |
| $20.31 | -3.97 | -16.4% | $17.08 | $20.91 | $17.00 | 17,173,100 | |
| $24.28 | -0.67 | -2.7% | $24.59 | $24.70 | $24.14 | 1,588,000 | |
| $24.95 | -0.19 | -0.8% | $25.26 | $25.39 | $24.60 | 1,453,500 | |
| $25.14 | +0.04 | +0.2% | $25.55 | $26.18 | $24.92 | 2,180,600 | |
| $25.10 | -0.33 | -1.3% | $24.99 | $25.40 | $24.72 | 1,629,400 | |
| $25.43 | +0.36 | +1.4% | $24.92 | $25.65 | $24.58 | 2,769,300 | |
| $25.07 | -1.02 | -3.9% | $25.82 | $25.98 | $24.83 | 1,186,900 | |
| $26.09 | -0.27 | -1.0% | $26.29 | $26.49 | $25.98 | 1,018,700 | |
| $26.36 | +0.02 | +0.1% | $26.32 | $26.47 | $25.78 | 1,527,800 | |
| $26.34 | +0.35 | +1.3% | $26.28 | $26.69 | $25.97 | 1,459,196 | |
| $25.99 | -0.11 | -0.4% | $26.13 | $26.14 | $25.14 | 1,370,092 | |
| $26.10 | +0.12 | +0.5% | $26.22 | $26.87 | $26.02 | 1,181,800 | |
| $25.98 | -0.80 | -3.0% | $26.33 | $26.43 | $25.68 | 1,484,300 | |
| $26.78 | +0.78 | +3.0% | $26.50 | $26.94 | $25.98 | 1,952,000 | |
| $26.00 | -0.15 | -0.6% | $25.88 | $26.31 | $25.46 | 1,900,700 | |
| $26.15 | +0.45 | +1.8% | $25.90 | $26.43 | $25.30 | 1,317,600 | |
| $25.70 | -0.26 | -1.0% | $25.73 | $25.93 | $25.30 | 1,684,500 | |
| $25.96 | -0.21 | -0.8% | $26.00 | $26.48 | $25.88 | 1,901,600 | |
| $26.17 | -0.54 | -2.0% | $26.84 | $27.31 | $26.11 | 1,781,400 | |
| $26.71 | +0.21 | +0.8% | $26.87 | $27.13 | $26.14 | 1,398,900 | |
| $26.50 | +0.25 | +1.0% | $25.78 | $26.84 | $25.70 | 3,022,600 | |
| $26.25 | +0.37 | +1.4% | $26.20 | $26.34 | $25.25 | 1,991,000 | |
| $25.88 | -0.29 | -1.1% | $26.51 | $26.77 | $25.58 | 1,330,600 | |
| $26.17 | +0.20 | +0.8% | $26.33 | $27.09 | $25.86 | 2,152,600 | |
| $25.97 | +0.73 | +2.9% | $25.80 | $26.08 | $25.20 | 2,774,200 | |
| $25.24 | +0.06 | +0.2% | $25.04 | $25.38 | $24.18 | 2,131,900 | |
| $25.18 | -0.55 | -2.1% | $25.80 | $25.99 | $24.41 | 1,825,200 | |
| $25.73 | +0.63 | +2.5% | $24.50 | $25.80 | $23.95 | 1,924,500 |
- Ticker
- NASDAQ:DYN
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 22, 2026
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Latest deck · Sep 29, 2026
World Muscle Society 31st Annual Congress 2026
Conference · 22 slides
Latest news
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Oct 22, 2026
Closed $15.62 (-1.0%) on Oct 23, 2026
Dyne Therapeutics Announces Additional One-Year Clinical Data from Phase 1/2 ACHIEVE Trial of Z-Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1 (DM1)
Sep 29, 2026
Closed $16.11 (-0.6%) on Sep 30, 2026
Dyne Therapeutics to Present Additional One-Year Clinical Data from Phase 1/2 ACHIEVE Trial of Z-Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1 (DM1) at Upcoming Medical Meetings
Sep 8, 2026
Closed $20.31 (-16.4%) on Sep 8, 2026
Dyne Therapeutics to Present Preclinical Data for Multiple Development Candidates for Duchenne Muscular Dystrophy (DMD) at 27th Annual NMSG Scientific Meeting
Sep 3, 2026
Closed $24.95 (-0.8%) on Sep 3, 2026
Dyne Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Jul 29, 2026
Closed $25.73 (+2.5%) on Jul 30, 2026
Dyne Therapeutics Announces U.S. FDA Clearance of Investigational New Drug (IND) Application for DYNE-302 in Facioscapulohumeral Muscular Dystrophy (FSHD)
Jul 28, 2026
Closed $25.90 (+1.1%) on Jul 28, 2026
Dyne Therapeutics Announces Pricing of Upsized $375 Million Public Offering of Common Stock
Jul 21, 2026
Closed $23.21 (-2.6%) on Jul 22, 2026
Dyne Therapeutics Announces U.S. FDA Acceptance of Biologics License Application (BLA) for Z-Rostudirsen in Exon 51 Duchenne Muscular Dystrophy (DMD)
Jul 20, 2026
Closed $23.45 (-1.2%) on Jul 20, 2026
Dyne Therapeutics Appoints Barry Greene to Board of Directors
Jun 22, 2026
Closed $20.26 (-2.9%) on Jun 23, 2026
Dyne Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(4)
Jun 19, 2026
Closed $20.87 (+5.4%) on Jun 22, 2026
Financings
Public offering of common stock
Jul 22, 2026
Made bigger: US$375.15M · US$20.5 a share · Morgan Stanley +5
Dealers: Morgan Stanley (co-lead), Jefferies (co-lead), Evercore ISI (co-lead), LifeSci Capital (co-lead), Raymond James (co-lead), Jones
Decks
World Muscle Society 31st Annual Congress 2026
Conference · 22 slides · Sep 29, 2026
RNA Leaders US 2026
Conference · 19 slides · Sep 25, 2026
44th Annual J.P. Morgan Healthcare Conference 2026
Conference · 31 slides · Jan 12, 2026
Technical Presentation (2026)
Technical · 17 slides · 2026
Dyne Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 33 in the last 12 months · 143 in all · newest Oct 22, 2026 · oldest 2020
- Decks
- 15 decks · latest Sep 29, 2026
Where Dyne Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:DYN · Home listing · This page | NASDAQ | United States | USD |
| BOATS:DYN | BOATS | United States | USD |
| BX Swiss:DYN | BX Swiss | Switzerland | CHF |
Log in to ask 6ix AI your own questions about Dyne Therapeutics, Inc.